Search results
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 18 hours agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?
Zacks via Yahoo Finance· 15 hours agoXencor (XNCR) witnessed a jump in share price last session on above-average trading volume. The...
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
The Record Gazette· 6 days agoTED is a serious, progressive, debilitating and potentially vision-threatening autoimmune disease that can cause proptosis (eye bulging), diplopia (double ...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 18 hours agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many other potential...
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide...
FOX 5 San Diego· 2 days agoImmunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune
Country music star ‘died twice’ after post-show collapse: ‘The Lord had more for me to do’
The Patriot-News· 14 hours agoColt Ford was trending again on Wednesday because … well it seems folks are still pretty, darned...
Celine Dion’s Hopes for a ‘Miracle’: ‘She’s Working Hard Every Day to Come Back and Sing’
Life & Style via Yahoo News· 7 hours agoWalking onto stage on the arm of her eldest son to announce Taylor Swift as this year’s album of the...
Hampton father gives up kidney to save his daughter's life
13 News, WVEC Hampton Roads· 1 day agoA father's love knows no bounds, and in Hampton, one father gave up his kidney to save his...
After 'reset,' Flagship startup lands $1.8B Bristol Myers Squibb deal - Boston Business Journal
The Business Journals· 4 days agoNissen's arrival coincided with Repertoire’s decision to scrap its two lead drugs and lay off 65...
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 2 days agoDelivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW. Phase 3 VELOS-4 study of tanfanercept in dry eye disease expected ...